Compliance in antiamblyopia occlusion therapy

P. Nucci, R. Alfarano, A. Piantanida, R. Brancato

Research output: Contribution to journalArticle


Antiamblyopia occlusion therapy relies on compliance. We retrospectively reviewed the charts of 496 amblyopic subjects. Measures of non-compliance included patient reporting and patient records of broken appointments. Out of 496 subjects, 92 (18%) failed to follow the occlusion regimen. Compliance with treatment was analyzed by age group, refractive error and type of strabismus. The failure rate was 82.6% for the unilateral high myopia group and 37.5% for the monofixation syndrome group. The risk for non-compliance appeared to be higher in the 1 to 2-year-old group (37%). The χ2-test showed the differences to be highly significant (P <0.0001). Children having lower initial visual acuity were also significantly less compliant (P <0.007). Several factors such as age, parental understanding, initial visual acuity and improvement rate seem to be involved in compliance.

Original languageEnglish
Pages (from-to)128-131
Number of pages4
JournalActa Ophthalmologica
Issue number1
Publication statusPublished - 1992


  • Amblyopia
  • Children
  • Compliance
  • Epidemiology
  • High myopia
  • Monofixation syndrome
  • Therapy

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Compliance in antiamblyopia occlusion therapy'. Together they form a unique fingerprint.

  • Cite this

    Nucci, P., Alfarano, R., Piantanida, A., & Brancato, R. (1992). Compliance in antiamblyopia occlusion therapy. Acta Ophthalmologica, 70(1), 128-131.